Parkinson’s disease subtypes: literature review


Keywords: Parkinson’s disease, Parkinson’s disease phenotypes, Parkinson’s disease subtypes, Parkinson’s disease prognosis.

Abstract

Annotation. Parkinson’s disease, like most neurodegenerative diseases, is clinically heterogeneous with a broad spectrum of motor and non-motor features. A number of studies have proposed and described subtypes of Parkinson’s disease based on the characteristics of symptoms, which can be grouped. Subtyping makes possible optimization of the research of Parkinson’s disease etiology, pathogenesis, prognosis and response to treatment, as subtypes should reflect the main pathomorphological and pathophysiological differences between patients. This review considered subtypes of Parkinson’s disease identified so far, grouped common concepts and understanding of the relationship between subtypes and disease progression. A systematic review of articles in PubMed between 2009 and 2020 was performed using the following search terms: “Parkinson’s disease subtypes”, “Parkinson’s disease phenotypes” for the time period of last 10 years (2009–2020). In this review article the most commonly identified subtypes of Parkinson’s disease and their distinguishing features were discussed. As a result, 12 articles were identified, among them, 3 were data driven (cluster analysis). The classification based on the motor features of the disease, suggested by Jankovic et al. in 1990, remains the most popular to this day (tremor-dominant, akinetic-rigid or so called postural instability with gait impairment and mixed), but it is not very reliable, because patients tend to switch subtypes as the disease progresses. Cluster data analysis studies lack reproducibility and the method itself is too complex to be routinely used in clinical practice. In addition, it is yet not clear, if we are dealing with subtypes or just different stages of the disease. Thus, it was detected that the existing methods of Parkinson’s disease subtyping by cluster data analysis and classification into motor subtypes cannot be considered fully correct and generally accepted, because the disease is not static and patients can change the subtype (especially in the early stages of the disease), although motor phenotypes utilization remains the most prevalent today. It is obvious, that subtyping requires inclusion of other features (genetic, molecular, neuroimaging) into analysis of the disease, in addition to clinical manifestations.

References

1. Aleksovski, D., Miljkovic, D., Bravi, D., & Antonini, A. (2018). Disease progression in Parkinson subtypes: the PPMI dataset. Neurol. Sci., 39 (11), 1971–1976. doi: 10.1007/s10072-018-3522-z

2. Burn, D. J., Landau, S., Hindle, J. V., Samuel, M., Wilson, K. C., Hurt, C. S., & Brown, R. G. (2012). Parkinson's disease motor subtypes and mood. Mov. Disord., 27 (3), 379–86. doi: 10.1002/mds.24041

3. De Pablo-Fernández, E., Lees, A. J., Holton, J. L., & Warner, T. T. (2019). Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease. JAMA Neurol., 76 (4), 470–479. doi: 10.1001/jamaneurol.2018.4377

4. Erro, R., Picillo, M., Amboni, M., Savastano, R., Scannapieco, S., Cuoco, S., … & Barone, P. (2019). Comparing postural instability and gait disorder and akinetic-rigid subtyping of Parkinson disease and their stability over time. Eur. J. Neurol., 26 (9), 1212–1218. doi: 10.1111/ene.13968

5. Fereshtehnejad, S. M., Romenets, S. R., Anang,. J B., Latreille, V., Gagnon, J. F., & Postuma, R. B. (2015). New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. JAMA Neurol., 72 (8), 863–73. doi: 10.1001/jamaneurol.2015.0703

6. Fereshtehnejad, S. M., Zeighami, Y., Dagher, A., & Postuma, R. B. (2017). Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression. Brain, 140 (7), 1959–1976. doi: 10.1093/brain/awx118

7. Herman, T., Weiss, A., Brozgol, M., Giladi, N., & Hausdorff, J. M. (2014). Gait and balance in Parkinson's disease subtypes: objective measures and classification considerations. J. Neurol., 261 (12), 2401–10. doi: 10.1007/s00415-014-7513-6

8. Huang, X., Ng, S. Y., Chia, N. S., Setiawan, F., Tay, K. Y., Au, W. L., … & Tan, L. C. (2019). Non-motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life. Eur. J. Neurol., 26 (3), 400–406. doi: 10.1111/ene.13803

9. Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., … & Weiner, W. (1990). Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology, 40 (10), 1529–34. doi: 10.1212/wnl.40.10.1529

10. Konno, T., Deutschländer, A., Heckman, M. G., Ossi, M., Vargas, E. R., & Strongosky, A. J. (2018). Comparison of clinical features among Parkinson's disease subtypes: A large retrospective study in a single center. J. Neurol. Sci., 386, 39–45. doi: 10.1016/j.jns.2018.01.013

11. Lawton, M., Baig, F., Rolinski, M., Ruffman, C., Nithi, K., May, M., … & Hu, M. T. M. (2015). Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort. J. Parkinsons Dis., 5 (2), 269–79. doi: 10.3233/JPD-140523

12. Lawton, M., Ben-Shlomo, Y., May, M. T., Baig, F., Barber, T. R., & Klein, J. C. (2018). Developing and validating Parkinson's disease subtypes and their motor and cognitive progression. J. Neurol. Neurosurg. Psychiatry, 89 (12), 1279–1287. doi: 10.1136/jnnp-2018-318337

13. Lewis, S. J., Foltynie, T., Blackwell, A. D., Robbins, T. W., Owen, A. M., & Barker, R. A. (2005). Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J. Neurol. Neurosurg. Psychiatry, 76 (3) 343–8. doi: 10.1136/jnnp.2003.033530

14. Marras, C., & Lang, A. (2013). Parkinson's disease subtypes: lost in translation? J. Neurol. Neurosurg. Psychiatry, 84 (4), 409–15. doi: 10.1136/jnnp-2012-303455

15. Mestre, T. A, Eberly, S., Tanner, C., Grimes, D., Lang, A. E., Oakes, D., & Marras, C. (2018). Reproducibility of data-driven Parkinson's disease subtypes for clinical research. Parkinsonism Relat Disord., 56, 102–106. doi: 10.1016/j.parkreldis.2018.07.009

16. Mu, J., Chaudhuri, K. R., Bielza, C., de Pedro-Cuesta, J., Larrañaga, P., & Martinez-Martin, P. (2017). Parkinson’s Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms. Front Aging Neurosci., 9, 301. doi: 10.3389/fnagi.2017.00301

17. Nutt, J. G. (2016). Motor subtype in Parkinson's disease: Different disorders or different stages of disease? Mov. Disord., 31 (7), 957–61. doi: 10.1002/mds.26657

18. Post, B., Merkus, M. P., de Haan, R. J., & Speelman, J. D. (2007). Prognostic factors for the progression of Parkinson's disease: a systematic review. Mov. Disord., 22 (13), 1839–51; doi: 10.1002/mds.21537

19. Selikhova, M., Williams, D. R., Kempster, P. A., Holton, J. L., Revesz, T., & Lees, A. J. (2009). A clinico-pathological study of subtypes in Parkinson’s disease. Brain, 132 (11), 2947–57. doi: 10.1093/brain/awp234

20. Simuni, T., Caspell-Garcia, C., Coffey, C., Lasch, S., Tanner, C., & Marek, K. (2016). How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort. Parkinsonism Relat Disord., 28, 62–7. doi: 10.1016/j.parkreldis.2016.04.027

21. Szeto, J. Y., O'Callaghan, C., Shine, J. M., Walton, C. C., Mowszowski, L., Naismith, S. L., … & Lewis, S. J. G. (2015). The relationships between mild cognitive impairment and phenotype in Parkinson’s disease. NPJ Parkinsons Dis., 1, 15015. doi: 10.1038/npjparkd.2015.15

22. van Rooden, S. M., Colas, F., Martínez-Martín, P., Visser, M., Verbaan, D., Marinus, J., … & van Hilten, J. J. (2011). Clinical subtypes of Parkinson's disease. Mov. Disord., 26 (1), 51–8. doi: 10.1002/mds.23346
Published
2020-10-12
How to Cite
Diachenko, P. Y., & Moskovko, G. S. (2020). Parkinson’s disease subtypes: literature review. Reports of Vinnytsia National Medical University, 24(3), 512-517. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2020-24(3)-23